Truist Financial
AMPH icon

Truist Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History

Truist Financial’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,661
Closed -$210K – 2547
2024
Q4 		$210K Sell
5,661
-64
-1% -$2.93K ﹤0.01% 2371
2024
Q3 		$278K Sell
5,725
-8,760
-60% -$384K ﹤0.01% 2176
2024
Q2 		$579K Sell
14,485
-895
-6% -$37.1K ﹤0.01% 1885
2024
Q1 		$675K Sell
15,380
-410
-3% -$21.2K ﹤0.01% 1808
2023
Q4 		$977K Buy
15,790
+1,480
+10% +$77.7K ﹤0.01% 1610
2023
Q3 		$658K Sell
14,310
-2,956
-17% -$161K ﹤0.01% 1771
2023
Q2 		$992K Sell
17,266
-16,138
-48% -$715K ﹤0.01% 1589
2023
Q1 		$1.25M Buy
33,404
+4,836
+17% +$159K ﹤0.01% 1451
2022
Q4 		$800K Buy
28,568
+20,640
+260% +$599K ﹤0.01% 1661
2022
Q3 		$223K Sell
7,928
-11,448
-59% -$374K ﹤0.01% 2241
2022
Q2 		$674K Hold
19,376
– – ﹤0.01% 1733
2022
Q1 		$696K Hold
19,376
– – ﹤0.01% 1803
2021
Q4 		$451K Hold
19,376
– – ﹤0.01% 2078
2021
Q3 		$368K Sell
19,376
-3,722
-16% -$72.9K ﹤0.01% 2201
2021
Q2 		$466K Buy
+23,098
New +$435K ﹤0.01% 2100

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Truist Financial's AMPH Position: Q1 2025 in Review

Truist Financial sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 5,661 shares — an estimated $210K sold.

Truist Financial first reported a position in AMPH in Q2 2021 and held it in 15 quarters. The position peaked at $1.25M in Q1 2023. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

  • Truist Financial reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Truist Financial sold 5,661 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $210K.
  • Truist Financial first reported a position in Amphastar Pharmaceuticals in Q2 2021 and held it in 15 quarters.
  • Truist Financial's Amphastar Pharmaceuticals position peaked at $1.25M in Q1 2023.
  • 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on Truist Financial's 13F filing for Q1 2025, filed 29 Apr 2025.